Lloyd Inc. of Iowa Recalls Levothroid Tablets Due to Quality Deviations
Lloyd Inc. of Iowa is recalling Levothroid tablets due to cGMP deviations and insufficient stability data. The recall covers 142,103 bottles distributed nationwide and to Puerto Rico.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, but the source text does not report any illnesses, injuries, or hospitalizations. The hazard is based on quality deviations and insufficient data rather than confirmed harm, fitting the 'voluntary precautionary recalls' or 'low-risk contamination' criteria for a Moderate score.
Plain-English summary
Lloyd Inc. of Iowa is recalling Levothroid (levothyroxine sodium tablets, USP), 100 mcg, 100 tablets per bottle. The recall is due to Current Good Manufacturing Practice (cGMP) deviations and insufficient data to determine that other lots are not affected by stability failures found in previous lots.
The affected product was manufactured by Lloyd Pharmaceutical, Shenandoah, IA, for Forest Pharmaceuticals, Inc. The firm distributed the bulk product to Forest Laboratories, Inc., which repackaged it into 100-tablet bottles. Distribution was made to 75 customers nationwide and in Puerto Rico. The total quantity recalled is 142,103 bottles.
Affected lot numbers include 1095184, 1095185, 1095186, 1095187 (Exp Apr-13), 1096370 (Exp May-13), and 1097547, 1097588, 1097589 (Exp Jul-13). Consumers should check their medication for these lot numbers and expiration dates. If the product matches the description, they should stop using it and contact their healthcare provider or pharmacist for guidance.
The recalled product
- Product
- Levothroid (levothyroxine sodium tablets, USP), 100 mcg, RX only, 100 tablets per bottle, Manufactured for Forest Pharmaceuticals, Inc, St. Louis, MO by Lloyd Pharmaceutical, Shenandoah, IA, NDC 0456-1323-01
- Manufacturer
- Lloyd Inc. of Iowa
- Category
- Drug — Prescription Medication
- Affected units
- 142,103
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (11)
- Lot #: 1095184
- 1095185
- 1095186
- 1095187
- Exp Apr-13
- 1096370
- Exp May-13
- 1097547
- 1097588
- 1097589
- Exp Jul-13.
Distribution
Part of a larger recall action
This product is one of 20 recalled by Lloyd Inc. of Iowa under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 20 products in this recall →Related recalls
Same manufacturer · Lloyd Inc. of Iowa
See all →- ModerateLloyd Inc. Recalls Thyro-Tab Tablets Due to cGMP Deviations
FDA (Drugs) · 2013-05-29
- ModerateLloyd Inc. Recalls Levothroid Tablets Due to Quality Deviations
FDA (Drugs) · 2013-05-29
- ModerateLloyd Inc. Recalls Thyro-Tab Tablets Due to Quality Control Deviations
FDA (Drugs) · 2013-05-29
- ModerateLloyd Inc. Recalls Levothroid Tablets Due to Stability Failures
FDA (Drugs) · 2013-05-29
- ModerateLloyd Inc. Recalls Thyro-Tab Tablets Due to Quality Deviations
FDA (Drugs) · 2013-05-29
Same hazard · quality deviation
See all →- ModerateNarcan Nasal Spray Recalled for Temperature Excursions During Storage
FDA (Drugs) · 2021-06-02
- ModerateCardinal Health Recalls Meloxicam Tablets Due to Temperature Excursions
FDA (Drugs) · 2021-06-02
- ModerateCardinal Health Recalls LYRICA Capsules Due to Temperature Excursions
FDA (Drugs) · 2021-06-02
- ModerateCardinal Health Recalls Advair HFA Inhalers Due to Temperature Excursions
FDA (Drugs) · 2021-06-02
- ModerateCardinal Health Recalls Oseltamivir Phosphate Oral Suspension Due to Temperature Excursions
FDA (Drugs) · 2021-06-02